Franklin Resources Inc. Reduces Stock Position in Fresenius Medical Care AG (NYSE:FMS)

Franklin Resources Inc. decreased its position in Fresenius Medical Care AG (NYSE:FMS) by 5.8% in the 4th quarter, HoldingsChannel reports. The firm owned 70,299 shares of the company’s stock after selling 4,341 shares during the period. Franklin Resources Inc.’s holdings in Fresenius Medical Care were worth $1,592,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of FMS. Moran Wealth Management LLC grew its holdings in Fresenius Medical Care by 9.1% in the 4th quarter. Moran Wealth Management LLC now owns 254,710 shares of the company’s stock valued at $5,767,000 after buying an additional 21,334 shares during the period. ABC Arbitrage SA acquired a new stake in shares of Fresenius Medical Care during the 4th quarter worth $4,215,000. Corient Private Wealth LLC raised its position in shares of Fresenius Medical Care by 3.4% in the 4th quarter. Corient Private Wealth LLC now owns 88,381 shares of the company’s stock worth $2,001,000 after buying an additional 2,918 shares during the period. QRG Capital Management Inc. boosted its holdings in Fresenius Medical Care by 16.7% in the fourth quarter. QRG Capital Management Inc. now owns 67,973 shares of the company’s stock valued at $1,539,000 after acquiring an additional 9,706 shares during the last quarter. Finally, Crossmark Global Holdings Inc. grew its position in Fresenius Medical Care by 2.2% during the fourth quarter. Crossmark Global Holdings Inc. now owns 64,287 shares of the company’s stock valued at $1,456,000 after acquiring an additional 1,398 shares during the period. 8.37% of the stock is owned by institutional investors and hedge funds.

Fresenius Medical Care Stock Up 2.8 %

Shares of Fresenius Medical Care stock opened at $24.64 on Tuesday. The company has a fifty day moving average price of $23.94 and a 200 day moving average price of $22.82. The company has a current ratio of 1.37, a quick ratio of 1.02 and a debt-to-equity ratio of 0.42. Fresenius Medical Care AG has a twelve month low of $17.93 and a twelve month high of $25.96. The stock has a market cap of $14.46 billion, a price-to-earnings ratio of 20.36, a price-to-earnings-growth ratio of 0.76 and a beta of 0.93.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on FMS shares. StockNews.com upgraded Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 5th. Truist Financial increased their target price on shares of Fresenius Medical Care from $23.00 to $25.00 and gave the stock a “hold” rating in a research report on Monday, January 6th.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.